Julia Etchin
Biogen (United States)(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, CAR-T cell therapy research, Nuclear Structure and Function, CRISPR and Genetic Engineering, DNA Repair Mechanisms
Most-Cited Works
- → An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element(2014)802 cited
- → The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice(2016)302 cited
- → Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells(2012)191 cited
- → Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2(2010)173 cited
- → KPT‐330 inhibitor of CRM1 (XPO1)‐mediated nuclear export has selective anti‐leukaemic activity in preclinical models of T‐cell acute lymphoblastic leukaemia and acute myeloid leukaemia(2013)173 cited
- → Recombination Mediator and Rad51 Targeting Activities of a Human BRCA2 Polypeptide(2006)124 cited
- → KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells(2016)121 cited
- → Small genomic insertions form enhancers that misregulate oncogenes(2017)96 cited
- → Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice(2015)84 cited